131 I‐Meta‐iodobenzylguanidine followed by busulfan and melphalan and autologous stem cell rescue in high‐risk neuroblastoma-Reference-Cited by-同舟云学术

131 I‐Meta‐iodobenzylguanidine followed by busulfan and melphalan and autologous stem cell rescue in high‐risk neuroblastoma

Published:2020-10-24 Issue:2 Volume:68 Page:
ISSN:1545-5009
Container-title:Pediatric Blood & Cancer
language:en
Short-container-title:Pediatr Blood Cancer

Author:

Giardino Stefano¹^ORCID,Piccardo Arnoldo²,Conte Massimo³,Puntoni Matteo⁴,Bertelli Enrica³,Sorrentino Stefania³,Montera Mariapina⁵,Risso Marco⁵,Caviglia Ilaria⁶,Altrinetti Vania²,Lanino Edoardo¹,Faraci Maura¹^ORCID,Garaventa Alberto³

Affiliation:

1. Hematopoietic Stem Cell Transplantation Istituto Giannina Gaslini Genoa Italy

2. Nuclear Medicine Department Ospedale Galliera Genoa Italy

3. Pediatric Oncology Unit Istituto Giannina Gaslini Genoa Italy

4. Clinical Trial Unit Scientific Directorate Ospedale Galliera Genoa Italy

5. Immunohematology and Transfusional Department Istituto Giannina Gaslini Genoa Italy

6. Infectious Disease Unit Istituto Giannina Gaslini Genoa Italy

Publisher

Wiley

Subject

Oncology,Hematology,Pediatrics, Perinatology, and Child Health

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/pbc.28775

Reference36 articles.

1. Trends in cancer incidence among children in the U.S;Gurney JG;Cancer,1996

2. Busulfan and melphalan versus carboplatin, etoposide, and melphalan as high-dose chemotherapy for high-risk neuroblastoma (HR-NBL1/SIOPEN): an international, randomised, multi-arm, open-label, phase 3 trial

3. Improved Survival of Children With Neuroblastoma Between 1979 and 2005: A Report of the Italian Neuroblastoma Registry

4. Treatment of high‐risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13‐cis‐retinoicacid. Children's Cancer Group;KMatthay K;N Engl J Med,1999

5. 1070 myeloablative megatherapy procedures followed by stem cell rescue for neuroblastoma: 17 years of European experience and conclusions

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A narrative review of 35 years of meta-[131I]iodobenzylguanidine therapy in neuroblastoma;EJC Paediatric Oncology;2024-06

2. Incidence of subclinical and overt hypothyroidism in children treated with [131I]mIBG: a systematic review and meta-analysis;The Quarterly Journal of Nuclear Medicine and Molecular Imaging;2024-04

3. Timing and chemotherapy association for 131-I-MIBG treatment in high-risk neuroblastoma;Biochemical Pharmacology;2023-10

4. A safety and feasibility trial of 131 I‐MIBG in newly diagnosed high‐risk neuroblastoma: A Children's Oncology Group study;Pediatric Blood & Cancer;2021-05-24

5. Factors Modifying Outcome After MIBG Therapy in Children With Neuroblastoma—A National Retrospective Study;Frontiers in Oncology;2021-04-12